Shengda Biopharm's subsidiary to build a D isoascorbic acid and sodium erythorbate project 09-23-2021

On August 27, Shengda Bio-pharm issued an announcement that the company's subsidiary Tongliao Shengda Bioengineering Co., Ltd. plans to invest RMB 270 million to build a D-isoascorbic acid and sodium erythorbate project with an annual output of 20,000 tons. This project is to be implemented, operated, and managed by Tongliao Shengda, a holding subsidiary of Shengda Biotech. The plans for the project consist of building a production line, building new fermentation workshops, extraction workshops, and supporting auxiliary workshops, and expanding production equipment and auxiliary facilities. The project will occupy a total construction area of 67,000 square meters.

The completion of this new project project will help promote the company's product diversification, expand the company's development space, and create new growth potential for the company. It will also enhance the company's comprehensive competitiveness, expand the company's broader business space, and benefit the company's long-term development.


D-isoascorbic acid and sodium erythorbate expected to see wide future use in Chinese food industry

D-isoascorbic acid and sodium erythorbate are water-soluble food antioxidants that have been approved by the World Food and Agriculture Organization and the World Health Organization (FAO and WHO) as safe food additives. Furthermore, these compounds can be efficiently produced without harming the environment, are they are non-toxic.

Compared with developed countries, D-isoascorbic acid and sodium erythorbate still have very limited uses and applications within China. As living standards in China continue to improve, the domestic food industry is expected to continue developing and expanding, and D-isoascorbic acid and sodium erythorbate are expected to see wide application in Chinese food products in the near future.

Shengda Biotech is a key food additive company both in China and around the world

According to the company's official website, Shengda Biotech is mainly engaged in the research and development, production, and sales of food and food additives. Its products include vitamin products such as biotin and folic acid, as well as biological preservatives such as nisin and natamycin. At the same time, the company is globally recognized and has earned many international certifications.

Shengda Biotech is one of the earliest companies in China to be engaged in the production of biotin and biological preservatives. It is a high-tech enterprise, and it has established a municipal academic workstation, a provincial technical center and a provincial research institute. Furthermore, it develops its own vitamin B products and biological preservatives. Shengda Biotech's products are major players in the Chinese market, and its subsidiary, Xinyinxiang, is one of the world's major suppliers of nisin and natamycin, and Xinyinxiang has been awarded many honorary titles by authorities in its local province of Zhejiang. In the future, Shengda Biotech will continue to focus food additives and products to increase food quality, with a particular focus on vitamin B2 and D3 products. Shengda Biotech also plans to develop an industrial green recycling model by which the traditional solid and liquid waste from the biological fermentation process can be re-used via new technology.

For more information , please check our resources on China’s food and feed market.

About CCM:

CCM is the leading market intelligence provider for China’s agriculture, chemicals, food & feed and life science markets. Founded in 2001, CCM offers a range of data and content solutions, from price and trade data to industry newsletters and customized market research reports. CCM is a brand of Kcomber Inc.

For more information about CCM, please visit or get in touch with us directly by emailing or calling +86-20-37616606.

Subscribe to our Newsletter


Next Press